| http://www.w3.org/ns/prov#value | - Testing for molecular abnormalities in single genes or for copy number alterations is already fairly common in clinical practice for breast, lung, colon, melanoma and other tumors (e.g., estrogen and progesterone receptor expression, expression or amplification of Her2/neu, KRAS mutations, EGFR mutations, BRAF V600E mutation, expression of c-KIT and BCR/ABL, PML/RAR and EML4-ALK translocations).
|
